This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

End-payers oppose Bausch, Lannett settlement on US states' price-fixing claims

( February 16, 2026, 23:00 GMT | Official Statement) -- MLex Summary: End-payer plaintiffs suing drug manufacturers in multidistrict litigation over alleged price-fixing filed an opposition to a proposed settlement between Bausch Health, Lannett Co. and US states. The settlement purports to release claims on behalf of consumers in 48 jurisdictions — consumers in 45 of those jurisdictions have claims pending against Bausch and Lannett in the multidistrict litigation — but the parties to the settlement have not included a plan of allocation that would allow the end-payers to determine whether the settlement is fair, reasonable and adequate, the filing in the US District Court for the District of Connecticut said.See attached document: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections